84 related articles for article (PubMed ID: 33328548)
21.
Li L; Yu C
Biomed Res Int; 2019; 2019():9824964. PubMed ID: 31737682
[TBL] [Abstract][Full Text] [Related]
22. Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer.
Shimizu T; Marusawa H; Watanabe N; Chiba T
Gastroenterol Clin North Am; 2015 Sep; 44(3):625-38. PubMed ID: 26314672
[TBL] [Abstract][Full Text] [Related]
23. Somatic alterations and mutational burden are potential predictive factors for metachronous development of early gastric cancer.
Sakuta K; Sasaki Y; Abe Y; Sato H; Shoji M; Yaoita T; Yagi M; Mizumoto N; Onozato Y; Kon T; Koseki A; Sato S; Murakami R; Miyano Y; Ueno Y
Sci Rep; 2020 Dec; 10(1):22071. PubMed ID: 33328548
[TBL] [Abstract][Full Text] [Related]
24. Association between
Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
[TBL] [Abstract][Full Text] [Related]
25. Successful Eradication of Helicobacter pylori Could Prevent Metachronous Gastric Cancer: A Propensity Matching Analysis.
Nakata R; Nagami Y; Hashimoto A; Sakai T; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Ohira M; Taira K; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y
Digestion; 2021; 102(2):236-245. PubMed ID: 31678978
[TBL] [Abstract][Full Text] [Related]
26. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.
Okada K; Suzuki S; Naito S; Yamada Y; Haruki S; Kubota M; Nakajima Y; Shimizu T; Ando K; Uchida Y; Hirasawa T; Fujisaki J; Tsuchida T
Gastrointest Endosc; 2019 Jun; 89(6):1152-1159.e1. PubMed ID: 30825537
[TBL] [Abstract][Full Text] [Related]
27. Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients.
Kwon YH; Heo J; Lee HS; Cho CM; Jeon SW
Aliment Pharmacol Ther; 2014 Mar; 39(6):609-18. PubMed ID: 24461252
[TBL] [Abstract][Full Text] [Related]
28. Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection.
Abe S; Oda I; Suzuki H; Nonaka S; Yoshinaga S; Nakajima T; Sekiguchi M; Mori G; Taniguchi H; Sekine S; Katai H; Saito Y
Endoscopy; 2015 Dec; 47(12):1113-8. PubMed ID: 26165734
[TBL] [Abstract][Full Text] [Related]
29. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
[TBL] [Abstract][Full Text] [Related]
30. Metachronous gastric cancer risk after endoscopic resection of early gastric cancer and H. pylori status.
Kato M
J Gastroenterol; 2019 May; 54(5):478-479. PubMed ID: 30770974
[No Abstract] [Full Text] [Related]
31. Molecular subtype switching in early-stage gastric cancers with multiple occurrences.
Takaoka S; Hirotsu Y; Ohyama H; Mochizuki H; Amemiya K; Oyama T; Ashizawa H; Yoshimura D; Nakagomi K; Hosoda K; Suzuki Y; Kojima Y; Omata M
J Gastroenterol; 2019 Aug; 54(8):674-686. PubMed ID: 30666417
[TBL] [Abstract][Full Text] [Related]
32. Genomic alterations in gastric cancers discovered via whole-exome sequencing.
Zhang J; Qiu W; Liu H; Qian C; Liu D; Wang H; Hu N; Tang YT; Sun J; Shen Z
BMC Cancer; 2018 Dec; 18(1):1270. PubMed ID: 30567531
[TBL] [Abstract][Full Text] [Related]
33. Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Mayakonda A; Lin DC; Assenov Y; Plass C; Koeffler HP
Genome Res; 2018 Nov; 28(11):1747-1756. PubMed ID: 30341162
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis.
Xiao S; Li S; Zhou L; Jiang W; Liu J
J Gastroenterol; 2019 Mar; 54(3):226-237. PubMed ID: 30251121
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of RECQL4 is associated with poor prognosis in patients with gastric cancer.
Chen H; Yuan K; Wang X; Wang H; Wu Q; Wu X; Peng J
Oncol Lett; 2018 Oct; 16(4):5419-5425. PubMed ID: 30250613
[TBL] [Abstract][Full Text] [Related]
36. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
37. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.
Choi JM; Kim SG; Choi J; Park JY; Oh S; Yang HJ; Lim JH; Im JP; Kim JS; Jung HC
Gastrointest Endosc; 2018 Sep; 88(3):475-485.e2. PubMed ID: 29800546
[TBL] [Abstract][Full Text] [Related]
38. ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.
Shen J; Ju Z; Zhao W; Wang L; Peng Y; Ge Z; Nagel ZD; Zou J; Wang C; Kapoor P; Ma X; Ma D; Liang J; Song S; Liu J; Samson LD; Ajani JA; Li GM; Liang H; Shen X; Mills GB; Peng G
Nat Med; 2018 May; 24(5):556-562. PubMed ID: 29736026
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
Choi IJ; Kook MC; Kim YI; Cho SJ; Lee JY; Kim CG; Park B; Nam BH
N Engl J Med; 2018 Mar; 378(12):1085-1095. PubMed ID: 29562147
[TBL] [Abstract][Full Text] [Related]
40. Clinical and radiological diversity in genetically confirmed primary familial brain calcification.
Koyama S; Sato H; Kobayashi R; Kawakatsu S; Kurimura M; Wada M; Kawanami T; Kato T
Sci Rep; 2017 Sep; 7(1):12046. PubMed ID: 28935882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
